JPRN-UMIN000000729已完成未知
Comprison of the renoprotecrive and the antihypertensive effects of Olmesartan vs Losartan + low dose diuretics in normoalbuminuric diabetic patients - Evaluation of renoprotective effects of Olmesartan in normoalbuminuric diabetic patients
Akita Olmesartan renoprotection study group0 个研究点目标入组 30 人开始时间: 2007年6月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Past history of microalbuminuria, overt proteinuria or any kidney diseases 2. Pregnancy 3. Severe liver dysfunction 4. Cancer 5. Poor glycemic control (HbA1c > 10%) 6. Other reasons for exclusion
研究者
相似试验
尚未招募
3 期
A clinical trial to study the effects of two antihyperlipidemics in patients with mixed dyslipidemia.CTRI/2010/091/000556Fax: 631-656-1006200
已完成
不适用
An exploratory clinical study of the renoprotective effect of empagliflozin and the verification of companion diagnostics in type 2 diabetes patientsType 2 diabetes mellitusJPRN-UMIN000023902Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences51
尚未招募
Unknown
Hiprex versus standard management for preventing urinary tract infections post intravesical botox injection for overactive bladder: A randomised controlled trialRenal and Urogenital - Other renal and urogenital disordersurinary tract infectionACTRN12624000500550Mercy Womens Hospital118
尚未招募
不适用
Renoprotective effect of combination therapy in hypertensive patients with renal diseases.Hypertensive patients with renal diseasesJPRN-UMIN000002752Division of nephrology, Kanazawa University Hospital200
已完成
不适用
Evaluation of renoprotective and hypotensive effects by combined use of irbesartan and amlodipine besilate in elderly patients with hypertension.HypertensionJPRN-UMIN000008841Kanazawa Medical University30